[Risks of topical treatments in pregnancy].
Machet
L
L
Service de Dermatologie, CHU Trousseau, Tours.
Vaillant
L
L
Lorette
G
G
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D011033:Podophyllin / Q000627:therapeutic use; D011247:Pregnancy; D012306:Risk
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000998:Antiviral Agents; D004364:Pharmaceutical Preparations; D011033:Podophyllin; D015474:Isotretinoin
Les risques des traitements topiques au cours de la grossesse.